Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Reimagining atrial fibrillation screening beyond age-based thresholds using AI
0
Zitationen
3
Autoren
2026
Jahr
Abstract
Atrial fibrillation (AF) affects over 50 million people worldwide and carries substantial downstream morbidity, mortality, and cost. Yet many contemporary screening programs rely primarily on age thresholds—an approach that is operationally simple but can be imprecise for identifying near-term risk. AI applied to handheld single-lead ECGs can predict incident AF with accuracy similar to established clinical risk scores, but real-world deployment remains limited by signal noise, workflow complexity, and unclear risk thresholds.
Ähnliche Arbeiten
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 · 11.554 Zit.
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 · 11.143 Zit.
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
2020 · 9.748 Zit.
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
2017 · 9.634 Zit.
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
2011 · 9.335 Zit.